AI assistant
Sending…
Theravance Biopharma, Inc. — Director's Dealing 2021
Feb 24, 2021
32537_dirs_2021-02-23_24f50d80-96ad-4403-a167-87b07fed7dc7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Theravance Biopharma, Inc. (TBPH)
CIK: 0001583107
Period of Report: 2021-02-20
Reporting Person: PASQUALONE FRANK (SVP, Chief Business Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-02-20 | Ordinary Shares | F | 26961 | $18.79 | Disposed | 439719 | Direct |
More from Theravance Biopharma, Inc.
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
May 7
Annual Report
2026
Mar 23
Regulatory Filings
2026
Mar 19
Director's Dealing
2026
Mar 18
Regulatory Filings
2026
Mar 3
Director's Dealing
2026
Feb 25
Director's Dealing
2026
Feb 25
Director's Dealing
2026
Feb 25
Director's Dealing
2026
Feb 25